Navigation Links
InterMune Reports Fourth Quarter and Full Year 2010 Financial Results and Business Highlights
Date:2/16/2011

BRISBANE, Calif., Feb. 16, 2011 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN) today announced results from operations for the fourth quarter and full year ended December 31, 2010.

InterMune reported net income for the fourth quarter of 2010 of $206.1 million, or $3.34 per diluted share, compared with a net loss of $28.6 million, or $0.62 per diluted share, in the fourth quarter of 2009. Net income for the full year 2010 was $122.4 million, or $2.13 per diluted share, compared with a net loss of $116.0 million, or $2.62 per diluted share, in 2009.

Results for the fourth quarter and full year 2010 include proceeds of $175.0 million from the sale of danoprevir in October 2010 and the accelerated recognition of approximately $57.3 million of remaining deferred revenue in connection with the termination of the 2006 Hoffmann-La Roche Inc. and F. Hoffmann-La Roche Ltd. (Roche) collaboration agreement.

Dan Welch, Chairman, Chief Executive Officer and President of InterMune said, "Our financial results in 2010 were driven by the sale of our rights to danoprevir to Roche, which enabled us to end the year with $295 million in cash and cash equivalents and provided the financial resources to independently maximize the world-wide value of pirfenidone. In December of 2010 we announced the adoption of a positive opinion by European regulatory authorities for the marketing authorization of Esbriet™ (pirfenidone) and we expect Esbriet to soon become the first therapy approved for the treatment of IPF patients in Europe. Regarding the U.S., we announced in January of 2011 our plan to conduct a Phase 3 study toward the potential U.S. FDA approval of Esbriet for the more than 100,000 Americans who suffer from IPF."

Recent Clinical Development, Business Highlights and Upcoming MilestonesEsbriet™ (pirfenidone):

  • InterMune reported on Dec
    '/>"/>

  • SOURCE InterMune, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. InterMune Announces Approval of Clinical Trial Authorization for Phase 1b Trial of ITMN-191
    2. InterMune Announces Start of Phase 1b Trial of ITMN-191
    3. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
    4. InterMune Provides Additional Information on ITMN-191 (R7227) MAD Study Results
    5. InterMune Announces Progress on Pirfenidone in IPF
    6. InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA
    7. InterMune Announces Start of 14-Day Triple Combination Study of ITMN-191 in Patients With Chronic Hepatitis C
    8. Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
    9. InterMune to Report Top-Line Results of Triple Combination Study of ITMN-191 in January 2009
    10. InterMune to Conduct Conference Call and Webcast to Discuss Results of Triple Combination Study of ITMN-191
    11. InterMune to Announce Results of Phase 3 CAPACITY Program of Pirfenidone in IPF Tomorrow, February 3
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/3/2015)... , March 3, 2015  This industry report package offers the most ... for safety glass in the world and in the top 10 global ... country reports from the following countries: Australia ... Germany , Italy , Japan ... United Kingdom , United States ...
    (Date:3/3/2015)... March 3, 2015  UnaliWear announces the market preview ... for seniors that guards against wandering and provides support ... new wearable – the Kanega watch ( http://www.UnaliWear.com ) ... use an easy speech interface rather than buttons, use ... human input. The watch goes wherever ...
    (Date:3/3/2015)... 3, 2015  Columbia Laboratories, Inc. (Nasdaq: ... Company"), a specialty pharmaceutical company focused on pharmaceuticals for ... the 27th Annual ROTH Conference, which will take place ... Dana Point, California . Management,s presentation ... a.m. Pacific Time (12:00 p.m. Eastern Time) in the ...
    Breaking Medicine Technology:Global Safety Glass Market to 2019 - Market Size, Top 10 Countries, Trends, and Forecasts 2UnaliWear's Wearable For Seniors Extends Independence With Advanced Technology 2
    ... BANGALORE, KARNATAKA, India, Oct. 19 Cardiac Science Corporation (Nasdaq: ... Code: 532391; NSE: OPTOCIRCUI] today announced they have entered into ... to acquire all of the outstanding shares of Cardiac Science ... represents a 10% premium to the closing price of Cardiac ...
    ... SAN DIEGO, Oct. 18 Althea Technologies, Inc., ... for biopharmaceuticals and parenteral drug products, announced today ... new INOVA H3-5 high-speed syringe filling line.  This ... commercial manufacturing facility in San Diego. The expanded ...
    Cached Medicine Technology:Opto Circuits to Acquire Cardiac Science 2Opto Circuits to Acquire Cardiac Science 3Opto Circuits to Acquire Cardiac Science 4Opto Circuits to Acquire Cardiac Science 5Opto Circuits to Acquire Cardiac Science 6Opto Circuits to Acquire Cardiac Science 7Althea Technologies Announces the Installation of a High-Speed Prefilled Syringe Line 2
    (Date:3/3/2015)... The biggest name in indoor air purification – ... fully integrated air quality platform that lets you track ... to remove dust, pollen and hazardous particles – while ... tablet or computer. , Sweden’s Blueair, which sells its ... unveil its Internet-enabled air sensor together with a host ...
    (Date:3/3/2015)... In March, 1% for the Planet , one of ... campaign, “Know Your Source,” which calls for consumers to pledge ... quest for ingredient awareness and better business practices. 1% for ... partners, including King Arthur Flour, Good Culture, Farm Aid, and ... food as an environmental issue, with a focus on knowing ...
    (Date:3/3/2015)... US Air Purifiers LLC , an Illinois ... pleased to announce that all Rabbit brand air purifiers are ... the west coast port strikes. This news comes just in ... , The port strikes, which have caused significant ... economic growth by as much as 1%, have hindered the ...
    (Date:3/3/2015)... 2015 Topical BioMedics, Inc., announces its March ... live on Tuesday, March 10th, 12pm – 1pm and 4pm ... accessible 24/7. , The Pain Management Workshops ... the March 10th workshop is “Opioid Addiction: An Over-Medicated ... U.S. represents 5% of the world’s population, yet consumers 99% ...
    (Date:3/3/2015)... The combinatorial, multi-gene GeneSight test ... outcomes for patients with depression, and their use ... individual genes that comprise the test, according to ... Clinic and Assurex Health, and published online by ... technology of the GeneSight Psychotropic test is based ...
    Breaking Medicine News(10 mins):Health News:Smart sensor and air purifier interconnect to track and trap dust, pollen and dangerous particles in home and workplace air 2Health News:1% For the Planet Asks Consumers to “Know Your Source” 2Health News:Rabbit Air Purifiers Back In Stock at US Air Purifiers LLC 2Health News:Rabbit Air Purifiers Back In Stock at US Air Purifiers LLC 3Health News:Topical BioMedics Hosts March Pain Management Webinar 2Health News:Topical BioMedics Hosts March Pain Management Webinar 3Health News:Topical BioMedics Hosts March Pain Management Webinar 4Health News:Topical BioMedics Hosts March Pain Management Webinar 5Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 2Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 3Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 4Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 5Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 6
    ... healthy crackle in the air! We have just been chipped in ... – chips! Wipe away that guilt// and let yourself have a ... complete range of McCain’s frozen chips has received the ‘green-signal’ from ... fat and saturated fat. The agency has accorded this brand of ...
    ... hundred villages in India will soon be well equipped ... centers - with the active involvement// of Indian American ... we would promote better hygiene, clean drinking water and ... also be given to creating awareness about vector borne ...
    ... with gonorrhea is probably twice as likely to develop bladder ... results in the British Journal of Cancer, lead author David ... the statement based on case studies of around 51,000 American ... men suffering from gonorrhea. Results analyzed showed that ...
    ... specially grown soy beans may prove to be successful ... says Tulane //University cancer researcher Matthew Burow. ... with ovarian and breast cancer tumors that are stimulated ... further growth of the tumors by interfering with the ...
    ... "gold-standard" amongst researchers for scientific studies. On the one ... has also questioned the worth of allopathic medicine practices, ... medicine (CAM) practices. Majority of CAM practices are difficult, ... ,The question arises as to whether EBM principles are ...
    ... blood thinning drugs quintupled during the 1990s, according to a ... than tenfold. ,Most of the increase is due ... prescribed to prevent blood clotting. Blood clots can lead to ... brain hemorrhage is a stroke caused by bleeding in the ...
    Cached Medicine News:Health News:Better Healthcare for 100 Villages - Courtesy Indian American Physicians 2Health News:Is Evidence-based Medicine Enough to Support Additional Research in Alternative Medicine? 2
    Kelman - McPherson angled tying forceps is long with tying platform 10 mm, serrated handle and polished finish....
    Castroviejo tying forceps, straight....
    Gerl titanium tying forceps has curved shanks, smooth jaws and 6 mm long tying platform. For 8-0 to 11-0 sutures....
    Tennant stainless steel tying forceps is extra delicate, straight with smooth jaws, 6 mm long platform, round handle with guide pin. For 9-0 to 11-0 sutures....
    Medicine Products: